pracinostat: Clinical Trials

9 trials of pracinostat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated. 5 Phase 2, 2 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 12Completed 2
Early Phase 11Completed 1
Phase 31Terminated 1

Follow pracinostat: new trials by email Literature Review of pracinostat trials Research Report on pracinostat

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body
pracinostat - Healthy Subjects
Phase 1CompletedHelsinn Healthcare SA62018-02-082019-08-08
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Pracinostat, Placebos, Azacitidine - Acute Myeloid Leukemia
Phase 3TerminatedHelsinn Healthcare SA4062017-06-232022-03-10
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
Pracinostat, Azacitidine - Myelodysplastic Syndromes
Phase 2TerminatedHelsinn Healthcare SA642017-06-012022-03-02
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Ruxolitinib, Pracinostat, Questionnaire - Myeloproliferative Diseases
Phase 2CompletedM.D. Anderson Cancer Center252015-01-122019-06-12
Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects
Pracinostat, Itraconazole, Ciprofloxacin - Healthy Volunteers, Non-smokers
Phase 1CompletedHelsinn Healthcare SA322014-05-012017-02-23
Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects
pracinostat - Healthy Volunteers, Moderate to Heavy Smokers
Early Phase 1CompletedHelsinn Healthcare SA282014-02-012017-02-23
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Pracinostat, Azacitidine - Acute Myeloid Leukemia
Phase 2CompletedHelsinn Healthcare SA502013-12-242021-02-09
Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
pracinostat, Azacitidine, Decitabine - Myelodysplastic Syndrome, MDS
Phase 2CompletedHelsinn Healthcare SA452013-12-012017-02-23
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
pracinostat, Placebo, Azacitidine - Myelodysplastic Syndrome
Phase 2CompletedHelsinn Healthcare SA1022013-06-012018-09-13

Conditions studied

Myelodysplastic Syndromes (3)  ·  Leukemia, Myeloid, Acute (2)  ·  Polycythemia Vera (1)  ·  Primary Myelofibrosis (1)

Sponsors

Helsinn Healthcare SA (8)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (8)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Guillermo Garcia-Manero, MD (4)  ·  Terry E O'Reilly, MD (2)  ·  Ehab Atallah, MD (1)  ·  Richard Ghalie, MD (1)  ·  Srdan Verstovsek, MD (1)

Results publications

PMID 30760466